Bank of New York Mellon’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-16,454
| Closed | -$255K | – | 4201 |
|
|
2024
Q1 | $255K | Sell |
16,454
-762
| -4% | -$11.8K | ﹤0.01% | 3843 |
|
|
2023
Q4 | $482K | Buy |
17,216
+1,178
| +7% | +$33K | ﹤0.01% | 3570 |
|
|
2023
Q3 | $763K | Sell |
16,038
-112
| -0.7% | -$5.33K | ﹤0.01% | 3326 |
|
|
2023
Q2 | $1.55M | Buy |
16,150
+3,627
| +29% | +$347K | ﹤0.01% | 2966 |
|
|
2023
Q1 | $1.42M | Buy |
12,523
+78
| +0.6% | +$8.85K | ﹤0.01% | 2980 |
|
|
2022
Q4 | $1.39M | Buy |
12,445
+105
| +0.9% | +$11.8K | ﹤0.01% | 3035 |
|
|
2022
Q3 | $1.59M | Buy |
12,340
+1,690
| +16% | +$217K | ﹤0.01% | 2976 |
|
|
2022
Q2 | $730K | Sell |
10,650
-626
| -6% | -$42.9K | ﹤0.01% | 3357 |
|
|
2022
Q1 | $1.61M | Buy |
11,276
+245
| +2% | +$34.9K | ﹤0.01% | 3053 |
|
|
2021
Q4 | $1.84M | Sell |
11,031
-2,677
| -20% | -$446K | ﹤0.01% | 3040 |
|
|
2021
Q3 | $1.91M | Buy |
13,708
+679
| +5% | +$94.5K | ﹤0.01% | 2998 |
|
|
2021
Q2 | $6.22M | Buy |
13,029
+2,657
| +26% | +$1.27M | ﹤0.01% | 2384 |
|
|
2021
Q1 | $4.27M | Sell |
10,372
-544
| -5% | -$224K | ﹤0.01% | 2508 |
|
|
2020
Q4 | $5.35M | Buy |
10,916
+1,517
| +16% | +$743K | ﹤0.01% | 2325 |
|
|
2020
Q3 | $5.32M | Buy |
9,399
+2,758
| +42% | +$1.56M | ﹤0.01% | 2181 |
|
|
2020
Q2 | $632K | Buy |
6,641
+910
| +16% | +$86.6K | ﹤0.01% | 3357 |
|
|
2020
Q1 | $409K | Buy |
5,731
+119
| +2% | +$8.49K | ﹤0.01% | 3467 |
|
|
2019
Q4 | $387K | Buy |
5,612
+1,058
| +23% | +$73K | ﹤0.01% | 3702 |
|
|
2019
Q3 | $365K | Buy |
4,554
+1,356
| +42% | +$109K | ﹤0.01% | 3699 |
|
|
2019
Q2 | $205K | Sell |
3,198
-1,244
| -28% | -$79.7K | ﹤0.01% | 3912 |
|
|
2019
Q1 | $611K | Buy |
4,442
+174
| +4% | +$23.9K | ﹤0.01% | 3451 |
|
|
2018
Q4 | $386K | Buy |
4,268
+301
| +8% | +$27.2K | ﹤0.01% | 3608 |
|
|
2018
Q3 | $602K | Hold |
3,967
| – | – | ﹤0.01% | 3542 |
|
|
2018
Q2 | $683K | Sell |
3,967
-683
| -15% | -$118K | ﹤0.01% | 3460 |
|
|
2018
Q1 | $682K | Buy |
4,650
+495
| +12% | +$72.6K | ﹤0.01% | 3418 |
|
|
2017
Q4 | $842K | Sell |
4,155
-70
| -2% | -$14.2K | ﹤0.01% | 3337 |
|
|
2017
Q3 | $1.36M | Buy |
4,225
+198
| +5% | +$63.5K | ﹤0.01% | 3049 |
|
|
2017
Q2 | $910K | Sell |
4,027
-66
| -2% | -$14.9K | ﹤0.01% | 3300 |
|
|
2017
Q1 | $923K | Sell |
4,093
-3
| -0.1% | -$677 | ﹤0.01% | 3287 |
|
|
2016
Q4 | $811K | Buy |
4,096
+723
| +21% | +$143K | ﹤0.01% | 3370 |
|
|
2016
Q3 | $829K | Buy |
3,373
+509
| +18% | +$125K | ﹤0.01% | 3270 |
|
|
2016
Q2 | $1.66M | Buy |
2,864
+899
| +46% | +$522K | ﹤0.01% | 2828 |
|
|
2016
Q1 | $1.04M | Buy |
1,965
+209
| +12% | +$111K | ﹤0.01% | 3034 |
|
|
2015
Q4 | $1.23M | Buy |
1,756
+750
| +75% | +$526K | ﹤0.01% | 3028 |
|
|
2015
Q3 | $597K | Buy |
+1,006
| New | +$597K | ﹤0.01% | 3468 |
|